在鼻腔疾病中EZH2的机制和治疗影响
Jiani Li1, Meng Wang1, Jing Yang1
1Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Clinical reviews in allergy & immunology
|May 4, 2025
概括
增强质同源2 (EZH2) 在细胞功能中起着关键作用,与各种癌症有关. 研究强调其与炎症性鼻腔疾病的联系以及针对性治疗的潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 增强性凝固同源2 (EZH2) 是多镇压复合体2中的一个关键蛋白质.
- EZH2调节细胞增殖,分化和功能所必需的基因转录.
- EZH2失调与各种癌症有关,包括前列腺癌和乳腺癌,以及免疫细胞的发育.
研究的目的:
- 审查有关EZH2在鼻腔疾病中的作用的研究进展.
- 探索EZH2向治疗鼻子疾病的潜力.
主要方法:
- 关于EZH2和鼻腔疾病研究的文献综述.
- 分析EZH2在细胞增殖,分化和免疫反应中的功能.
- 调查EZH2与炎症性鼻病和瘤之间的相关性.
主要成果:
- EZH2参与调节对细胞功能至关重要的基因.
- EZH2的失调与癌症的发展有关.
- 新出现的证据将EZH2与炎症性鼻病和鼻瘤联系起来.
结论:
- EZH2是导致鼻腔疾病发展的重要因素.
- 向EZH2为鼻腔病理提供了一个有前途的治疗途径.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Drugs Used in Upper Respiratory Disorders: Overview
129
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
129
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
151
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
151
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


